Carisma Therapeutics, Inc. CARM
0.00 USD 0.00 (+100.00%)
At closeNov 10, 2026, 4:00 PM EST
0.12 +0.12 +29,425.00%
After hours · Nov 10, 4:00 PM ET
0.0263 Day range 0.0324
0.0001 52-week range 0.10
- YTD
- -99.07%
- 1 year
- -99.13%
News
businesswire.com Carmila: 2026 H1 Results PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): 2026 EPS1 guidance raised to €1.87 (from €1.84, vs €1.81 in 2025) Now expecting 3.3% EPS growth in 2026 Guidance upgrade driven by…
defenseworld.net Critical Review: Carisma Therapeutics (NASDAQ:CARM) vs. Protalex (OTCMKTS:PRTX) Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Protalex (OTCMKTS:PRTX - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies…
businesswire.com Carmila: 2025 Annual Results PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): Three growth engines: NRI up 8.8% to €403.1 million Organic growth: adding 3.5% to net rental income, outpacing indexation by 110 basis…
defenseworld.net Financial Comparison: Context Therapeutics (NASDAQ:CNTX) vs. Carisma Therapeutics (NASDAQ:CARM) Context Therapeutics (NASDAQ: CNTX - Get Free Report) and Carisma Therapeutics (NASDAQ: CARM - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast…
prnewswire.com Carisma Announces Delisting from Nasdaq and SEC Deregistration PHILADELPHIA , Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to…
defenseworld.net Head-To-Head Survey: Achieve Life Sciences (NASDAQ:ACHV) vs. Carisma Therapeutics (NASDAQ:CARM) Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Achieve Life Sciences (NASDAQ: ACHV - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare…
feeds.newsfilecorp.com Carmanah Minerals Engages Warrior Drilling for Heritage Project; Targets Historic Eagle Zone on Burin Trend, NL Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Carmanah Minerals Corp. (CSE: CARM) ("Carmanah" or the "Company") is pleased to
defenseworld.net Comparing Cassava Sciences (NASDAQ:SAVA) and Carisma Therapeutics (NASDAQ:CARM) Carisma Therapeutics (NASDAQ: CARM - Get Free Report) and Cassava Sciences (NASDAQ: SAVA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Dow Tumbles Over 1%; Nio Shares Edge Lower After Q2 Results 
benzinga.com Nasdaq Down 1%; Signet Jewelers Earnings Top Views 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session 
benzinga.com Carisma Therapeutics To Receive $5M Investment From Ocugen As Part of Merger With Ocugen Subsidiary OrthoCellix 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
businesswire.com Carmila - First-half 2025 Results: Acceleration in Growth and Recurring Earnings Outlook Revised Upwards PARIS--(BUSINESS WIRE)--Regulatory News: Marie Cheval, Chair and Chief Executive Officer of Carmila (Paris:CARM), commented: “Carmila's accelerated growth in the first half of 2025 reflects the…
globenewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, CARM, ENZB on Behalf of Shareholders NEW YORK, July 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
prnewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders NEW YORK , June 27, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
prnewswire.com SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE and CARM on Behalf of Shareholders NEW YORK , June 23, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or…
businesswire.com CARM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Carisma Therapeutics Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Carisma Therapeutics Inc. (NASDAQ: CARM) and OrthoCellix, Inc. is fair to Carisma…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
globenewswire.com Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc.…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Why Stitch Fix Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
prnewswire.com Carisma Therapeutics Provides Corporate Updates Company to explore strategic alternatives to advance liver fibrosis and oncology assets and reduce operational cash burn PHILADELPHIA , March 31, 2025 /PRNewswire/ -- Carisma Therapeutics Inc.…
prnewswire.com Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference PHILADELPHIA , Feb. 19, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Michael…
prnewswire.com Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference PHILADELPHIA , Feb. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused therapeutics, today announced that Steven Kelly,…
benzinga.com Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket 
prnewswire.com Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline Resources realigned to focus primarily on in vivo macrophage engineering platform for fibrosis, oncology and autoimmune disease therapies Development of CT-0525 to be discontinued; workforce reduced…
prnewswire.com Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference PHILADELPHIA , Nov. 27, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing…